Information to come.

To reduce bronchospasm in patients with COPD.

DuoNeb is typically used when those with COPD continue to have evidence of bronchospasm and require a second fast-acting bronchodilator.

The normal dose of DuoNeb solution is one unit dose vial (containing 0.5 mg of Ipratropium Bromide with 3.0 mg of Albuterol Sulfate) taken via nebulizer four times a day. Patients may take additional nebulizer treatments as required by their physician. DuoNeb is for adults; safety and efficacy have not been determined in children.

DuoNeb should be used in a nebulizer with a mask or mouthpiece, and is taken by inhalation over a period of 5 to 15 minutes.

DuoNeb should be used a replacement if using the two drugs Albuterol Sulfate and Ipratopium Bromide as a nebulizer treatment in separate vials so that the two solutions are combined in one premixed, pre-measured unit dosage. This will improve ease of use and help to avoid medication errors.

• paradoxical bronchospasm
• dizziness
• nervousness
• tremor
• hoarseness
• insomnia
• muscle aches
• increased sputum
• bad taste
• headache
• flu
• chest pain
• edema
• fatigue
• dry mouth
• diarrhea
• upset stomach
• increased heart rate or blood pressure
• chest pain

Use with caution if you have cardiac disorders, especially coronary insufficiency, cardiac arrhythmias, and hypertension. Use with caution if you have narrow-angle glaucoma, prostatic hypertrophy, bladder-neck obstruction, convulsive disorders, hyperthyroidism, diabetic mellitus, in those unusually responsive to other bronchodilators, or if you have kidney or liver disease.

This medication has a history of hypersensitivity to soya lecithin or related food products, such as soybean and peanuts.

Store between 59°F (15°C) and 86°F (30°Celsius). Avoid excess humidity. For optimal results the canister should be at room temperature before use. Shake well before using.